September 17, 2021. Patients Without Antibodies Against Coronavirus OC43 Nucleocapsid Protein are at Higher Risk for Critical COVID-19

picture_hive_covid_news_updates.jpg

This following article is a multi-center non-interventional study which aimed to determine the presence or absence of coronavirus OC43 nucleocapsid protein antibody in ICU versus non-ICU COVID-19 patients

Patients with critical COVID-19 infection had significantly lower levels of coronavirus OC43 nucleocapsid protein antibody.

This findings are important because it can serve to stratify patients with COVID-19 according to the risk of severe disease. It also may help identify people who would need vaccination

Any information or statement present in this post does not replace your health care provider’s advice or treatment. This blog does not provide medical advice, prescribe medications or therapies, or diagnose conditions, it only expresses an opinion. If you have a health-related question or condition, confer with your healthcare provider.


0
0
0.000
3 comments